Abstract Background: Hematologic abnormalities are a clinical concern during docetaxel-containing chemotherapy. This study aimed to characterize paired hematologic changes and study-defined cytopenia and explore associations with candidate genetic variants. Method: This retrospective study included 67 adults with solid tumors receiving docetaxel (70 mg/m2) in combination regimens between June 2021 and March 2022.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Li-Shan
Contact Li-Shan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack